Britain's blue chips are poised to open a bit higher this morning taking their cue from higher Asian markets overnight.
Meanwhile, on Wall Street Monday, equities went higher boosted by tech companies and the absence of any 'bad news'.
Britain's market landscape was dominated by the continuing AstraZeneca/ Pfizer bid saga, which reached a close yesterday,
The US group doesn’t want to fight out a hostile takeover, and today Astra’s board rejected a final proposed bid worth £69bn – or £55.00 per AstraZeneca share, comprising £24.76 in cash and 1.747 Pfizer shares. Astra said the terms undervalue the company and “its attractive prospects”.
AstraZeneca shed around 11% and with the deal now off the table the FTSE 100 ended the day 0.16%, 11 points, lower at 6,844.
Today, analysts at spreadbetting firm IG Index are calling FTSE100 to open around 2.5 points higher.
In Asia, shares are moving higher after the US gains, with Japan's Nikkei going strong, up over 105 points at 14,111 after recent sessions of losses, while the Shanghai Composite is up three.
As well asa clutch of results announcements,including from High Street bellwether Marks & Spencer (LON:MKS), investors will be eyeing UK inflation numbers.